Private testing lab network must be maintained as Covid-19 tests reduce, says Cambridge Clinical Laboratories CEO

The CEO of Milton-based Cambridge Clinical Laboratories, Dr Anthony Cooke has said it is important the private testing lab network does not disappear as Covid-19 tests reduce.

He was speaking after being announced as chair of the scientific advisory board for The Laboratory and Testing Industry Organisation.

The trade association for medical testing companies and laboratories has a core ethical purpose and is led by an independent director.

Overseen by an advisory board, it discusses the issues facing the industry and decides the direction of the LTIO. The advisory board can also establish groups of interested persons to examine particular areas of interest or concern.

Dr Cooke said: “It’s a privilege to be offered this position. The UK now has a significant private sector lab testing network, many who are new to this industry but have striven hard to get accredited and I for one do not want to see them disappear just because Covid-19 testing is reducing.

“At a time when the NHS is severely under pressure and has a massive backlog of patients, we need people of vision in government who can see ways to use this new-found expertise and capacity to improve healthcare outcomes for everyone in the UK.

“At a time when levelling up is being talked about, the disparities in healthcare provision around the UK need to be sorted once and for all.”

Read more

Cambridge Clinical Laboratories offers Covid-19 travel tests directly to consumers